Percentage of Participants With Depressive Recurrence After Time (t) in Days [clinicaltrials_resource:NCT00105989/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Percentage of Participants With Depressive Recurrence After Time (t) in Days [clinicaltrials_resource:NCT00105989/outcome/1]
Bio2RDF identifier
NCT00105989/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00105989/outcome/1
analysis [clinicaltrials_vocabulary:analysis]
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
All randomized patients. Intent to Treat analysis.
N=Number of female randomized ...... 3-5. Intent to Treat analysis.
N=Number of male randomized pa ...... 3-5. Intent to Treat analysis.
Number of enrolled patients in ...... (2 patients in Continuation).
Number of enrolled patients in ...... ess. Intent to Treat analysis.
Number of enrolled patients in ...... pay. Intent to Treat analysis.
Number of enrolled patients in ...... ent. Intent to Treat analysis.
Number of female enrolled pati ...... ent. Intent to Treat analysis.
Number of male enrolled patien ...... ent. Intent to Treat analysis.
Number of patients with a base ...... lue. Intent to Treat analysis.
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
Every Visit from Week 0 up to Week 10 (Acute)
Every Visit from Week 10 up to Week 34 (Continuation)
Every Visit from Week 34 up to Week 86 (Maintenance Phase)
Every Visit from Week 35 up to Week 86 (Maintenance Phase)
Week 0 and Week 10 (Acute) and Week 34 (Continuation)
Week 0 and Week 10 (Acute) and Week 34 (Continuation)
Week 0 and Week 10 (Acute) and Week 34 (Continuation)
Week 0 and Week 10
Week 0 through Week10 (Acute) through Week 34 (Continuation)
Week 10 (Acute) and Week 34 (Continuation)
type [clinicaltrials_vocabulary:type]
alternate
Percentage of Participants With Depressive Recurrence After Time (t) in Days
@en
identifier
clinicaltrials_resource:NCT00105989/outcome/1
title
Recurrence: Clinical Global Im ...... inued due to lack of efficacy.
@en
type
label
Percentage of Participants Wit ...... esource:NCT00105989/outcome/1]
@en